Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Multicentre Trial Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer (REaCT-70)

NCT04921137 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT04921137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04921137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Multicentre Trial Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer (REaCT-70)
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 4
Overall status
Recruiting
Start date
August 19, 2021
Completion date
May 31, 2036
Enrollment
500 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer